MidAmerica Division, Inc. c/o Centerpoint Medical Center

Independence, Missouri 64057

0 studies enrolling now · 3 studies all time

What they study most

Diffuse Large B-cell Lymphoma, HER2-positive Breast Cancer, Non-small Cell Lung Cancer

Studies at this site

• A Study of Tucatinib vs. Placebo in Combination With Ado-trastuzumab Emtansine (T-DM1) for Patients With Advanced or Metastatic HER2+ Breast Cancer — Running, not enrolling
• Brentuximab Vedotin Plus Lenalidomide and Rituximab for the Treatment of Relapsed/Refractory DLBCL — Running, not enrolling
• An Open-label Study of Encorafenib + Binimetinib in Patients With BRAFV600-mutant Non-small Cell Lung Cancer — Completed